- Home
- / Belite Bio
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Belite Bio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$69.8
2024-10-29
Market Capitalization
$2.1 B
2024-10-29
CreditSafe Score
?
Score changed on Jul 13, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| General and administrative expense | 4.0M | 6.8M | 10.1M | 38.8M |
| Operating expense total | 12.8M | 40.0M | 84.2M | |
| Depreciation and amortization | 12.0K | |||
| EBIT | (12.8M) | (31.7M) | (40.0M) | (84.2M) |
| Interest income | 23.0K | 74.0K | 3.7M | 6.6M |
| Interest expense | 25.0K | 1.0K | ||
| Pre tax profit | (12.6M) | (31.6M) | (36.1M) | (77.6M) |
| Income tax expense | 9.0K | 6.0K | ||
| Net Income | (12.6M) | (31.6M) | (36.1M) | (77.6M) |
| EPS | (0.6) | (1.0) | (1.2) | (2.3) |